DrugCite
Search

LOXAPINE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Loxapine Adverse Events Reported to the FDA Over Time

How are Loxapine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Loxapine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Loxapine is flagged as the suspect drug causing the adverse event.

Most Common Loxapine Adverse Events Reported to the FDA

What are the most common Loxapine adverse events reported to the FDA?

Neuroleptic Malignant Syndrome
36 (2.01%)
Pyrexia
31 (1.73%)
Cardiogenic Shock
27 (1.51%)
Somnolence
26 (1.45%)
Cardiac Arrest
24 (1.34%)
Agitation
23 (1.29%)
Coma
23 (1.29%)
Overdose
23 (1.29%)
Tachycardia
22 (1.23%)
Blood Creatine Phosphokinase Increa...
20 (1.12%)
Hypoglycaemia
19 (1.06%)
Show More Show More
Disseminated Intravascular Coagulat...
18 (1.01%)
Electrocardiogram Qt Prolonged
18 (1.01%)
Malaise
18 (1.01%)
Renal Failure
18 (1.01%)
Fall
17 (.95%)
Dyskinesia
15 (.84%)
Vomiting
15 (.84%)
Asthenia
14 (.78%)
Cardio-respiratory Arrest
14 (.78%)
Extrapyramidal Disorder
14 (.78%)
Hypotension
14 (.78%)
Extremity Necrosis
13 (.73%)
Hyperhidrosis
13 (.73%)
Hypothermia
13 (.73%)
Intestinal Obstruction
13 (.73%)
Loss Of Consciousness
13 (.73%)
Septic Shock
13 (.73%)
Insomnia
12 (.67%)
Nausea
12 (.67%)
Urinary Retention
12 (.67%)
Colitis Ischaemic
11 (.62%)
Cyanosis
11 (.62%)
Hyperthermia
11 (.62%)
Aggression
10 (.56%)
Cytolytic Hepatitis
10 (.56%)
Death
10 (.56%)
Dyspnoea
10 (.56%)
Renal Failure Acute
10 (.56%)
Suicide Attempt
10 (.56%)
Blood Glucose Increased
9 (.5%)
Blood Pressure Decreased
9 (.5%)
Headache
9 (.5%)
Hyponatraemia
9 (.5%)
Leukocytosis
9 (.5%)
Psychotic Disorder
9 (.5%)
Pulmonary Embolism
9 (.5%)
Sepsis
9 (.5%)
Tremor
9 (.5%)
Anxiety
8 (.45%)
Constipation
8 (.45%)
Disturbance In Attention
8 (.45%)
Heart Rate Increased
8 (.45%)
Multiple Drug Overdose
8 (.45%)
Mydriasis
8 (.45%)
Pneumonia Aspiration
8 (.45%)
Respiratory Disorder
8 (.45%)
Rhabdomyolysis
8 (.45%)
Weight Increased
8 (.45%)
Alanine Aminotransferase Increased
7 (.39%)
Altered State Of Consciousness
7 (.39%)
Ascites
7 (.39%)
Completed Suicide
7 (.39%)
Confusional State
7 (.39%)
Convulsion
7 (.39%)
Delirium
7 (.39%)
Depressed Level Of Consciousness
7 (.39%)
Dysarthria
7 (.39%)
Ileus Paralytic
7 (.39%)
Toxic Epidermal Necrolysis
7 (.39%)
Abdominal Pain
6 (.34%)
Abnormal Behaviour
6 (.34%)
Aspartate Aminotransferase Increase...
6 (.34%)
Cholestasis
6 (.34%)
Drug Interaction
6 (.34%)
Drug Withdrawal Syndrome
6 (.34%)
Hyperprolactinaemia
6 (.34%)
Hypotonia
6 (.34%)
Lactic Acidosis
6 (.34%)
Myocardial Infarction
6 (.34%)
Neutropenia
6 (.34%)
Oedema
6 (.34%)
Respiratory Distress
6 (.34%)
Status Epilepticus
6 (.34%)
Sudden Death
6 (.34%)
Urinary Tract Infection
6 (.34%)
Visual Acuity Reduced
6 (.34%)
Apathy
5 (.28%)
Arrhythmia
5 (.28%)
Diarrhoea
5 (.28%)
Faecaloma
5 (.28%)
Hepatitis
5 (.28%)
Intestinal Ischaemia
5 (.28%)
Irritability
5 (.28%)
Ischaemic Stroke
5 (.28%)
Leukopenia
5 (.28%)
Obstructive Airways Disorder
5 (.28%)
Oedema Peripheral
5 (.28%)
Parkinsonism
5 (.28%)
Pruritus
5 (.28%)
Salivary Hypersecretion
5 (.28%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Loxapine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Loxapine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Loxapine

What are the most common Loxapine adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Loxapine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Loxapine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Loxapine According to Those Reporting Adverse Events

Why are people taking Loxapine, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
81
Psychotic Disorder
70
Product Used For Unknown Indication
67
Agitation
36
Schizophrenia
29
Bipolar Disorder
28
Show More Show More
Abnormal Behaviour
14
Mental Disorder
13
Delusion
11
Schizophrenia, Paranoid Type
10
Anxiety
7
Bipolar I Disorder
7
Mania
6
Foetal Exposure During Pregnancy
6
Overdose
5
Delirium
5
Ill-defined Disorder
5
Aggression
5
Dementia Alzheimers Type
5
Depression
5
Dissociative Identity Disorder
4
Persecutory Delusion
4
Dementia
4
Brief Psychotic Disorder With Marke...
3
Major Depression
2
Autism
2
Suicide Attempt
2
Schizoaffective Disorder
2
Paranoia
2
Chronic Obstructive Pulmonary Disea...
2
Hypertension
2
Patient Isolation
2
Suicidal Ideation
2
Psychiatric Decompensation
2
Unevaluable Event
2
Psychiatric Symptom
2
Obsessive-compulsive Disorder
2
Nervousness
1
Hallucination
1
Insomnia
1
Anxiolytic Therapy
1
Childhood Psychosis
1
Affective Disorder
1
Drug Exposure During Pregnancy
1
Maternal Exposure Timing Unspecifie...
1
Nightmare
1
Hiv Infection
1
Intervertebral Disc Degeneration
1
Wrong Drug Administered
1
Traumatic Brain Injury
1
Sleep Disorder
1

Drug Labels

LabelLabelerEffective
LoxapineMylan Pharmaceuticals Inc.15-SEP-10
Loxapine Succinate REMEDYREPACK INC. 30-NOV-10
Loxapine Succinate REMEDYREPACK INC. 08-DEC-10
LoxapineWatson Laboratories, Inc.04-FEB-11
LoxapineUDL Laboratories, Inc.11-FEB-11
Loxapine SuccinateREMEDYREPACK INC. 26-APR-11
Loxapine SuccinateREMEDYREPACK INC. 15-AUG-11
LoxapineLannett Company, Inc.16-AUG-11
Loxapine SuccinateREMEDYREPACK INC. 15-SEP-11
Loxapine SuccinateREMEDYREPACK INC. 15-SEP-11
AdasuveAlexza Pharmaceuticals, Inc.21-DEC-12

Loxapine Case Reports

What Loxapine safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Loxapine. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Loxapine.